THE Australian Pharmacy Liaison
Forum (APLF) members said
they were concerned about the
possibility of generic oxycodone in
a non-tamperproof form, approved
from this month on (PD 03 Jun).
The APLF said it had concerns
that, should a non-tamper-proof
formulation become available
again, pharmacists could be at risk
in the workplace and oxycodone
abuse could occur.
MEANWHILE the APLF has agreed
to support the ‘Building upon
pharmacists’ practice in Australia:
a vision for the profession’, with a
consumer version to be developed.
The project would be officially
launched at the PAC conference.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Sep 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Sep 14
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.